WASHINGTON – BIO President & CEO John F. Crowley released the following statement on the results of the 2024 U.S. election:
“We look forward to working closely with President-elect Trump, his incoming Administration, and members of Congress on both sides of the aisle to ensure that we have leadership in government that advances the ‘virtuous circle’ of innovation coming from America’s great biotechnology companies.
“The public health and our national security are best served by strong leadership that respects and advances science and medicine and ensures that the United States and our allies continue to lead the world in biotechnology.”
About BIO
BIO is the premier biotechnology advocacy organization representing biotech companies, industry leaders, and state biotech associations in the United States and more than 35 countries around the globe. BIO members range from biotech start-ups to some of the world’s largest biopharmaceutical companies – all united by the same goal: to develop medical and scientific breakthroughs that prevent and fight disease, restore health, and improve patients’ lives. BIO also organizes the BIO International Convention and a series of annual conferences that drive partnerships, investment, and progress within the sector. Learn more at bio.org